Mats Wahlström has extensive experience in the healthcare industry, having served as CEO and CFO of large international companies in the renal field. Mats currently serves as CEO and Chairman of KMG Capital Partners, LLC, Chairman of PCI | HealthDev, and Chairman of Caduceus Medical Holdings, LLC. He also serves as a Board Member and member of the Audit/Finance Committee of Coherus Biosciences, a private biotech company. He was appointed to the Board of Directors of Zynex, Inc. in October 2010, and currently serves on the Boards of Getinge AB and Alteco Medical AB. Mats served as a director of Health Grades, Inc., a NASDAQ-listed healthcare ratings company, from March 2009 through its sale to a private equity firm in October 2010.
From January 2004 through December 2009, Mats served as co-CEO of Fresenius Medical Care North America and from November 2002 through December 2009 as President and CEO of Fresenius Medical Services, which operates more than 1,700 dialysis clinics in the U.S. Prior to joining Fresenius Medical Care in 2002, he held various positions at Gambro AB in Sweden, including President and CEO of Gambro North America as well as CFO of the Gambro Group.
As Chairman of the Board of Managers, Mats works closely with the board and the management team of the Company to further refine the Company's business model and to accelerate the growth of the Company.
Mats has a BS in Economics and Business Administration from the University of Lund, Sweden.